Knivsta, Sweden

Gail Isabel Reid Adam

This inventor holds 1 USPTO granted patent. Top assignee: Sequenom-Gemini Limted. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gail Isabel Reid Adam. Retrieved from https://idiyas.com/inventor/gail-isabel-reid-adam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gail Isabel Reid Adam: Innovator in Heart Failure Detection

Introduction

Gail Isabel Reid Adam is a notable inventor based in Knivsta, Sweden. He has made significant contributions to the field of medical diagnostics, particularly in the detection of heart failure. His innovative work has the potential to improve patient outcomes through early diagnosis.

Latest Patents

Gail holds a patent for "Reagents and methods for detection of heart failure." This invention provides novel reagents, kits, and methods for diagnosing predisposition to left ventricular heart failure. The diagnosis is based on the analysis of polymorphic variants of the genomic nucleic acid set forth in SEQ ID NO:1. This patent represents a significant advancement in the field of cardiology.

Career Highlights

Gail is currently associated with Sequenom-Gemini Limited, where he continues to work on innovative solutions in medical diagnostics. His expertise and dedication to research have positioned him as a key figure in his field.

Collaborations

Gail collaborates with esteemed colleagues, including Maria Kristina Andersson and Lars Gunnar Ture Berglund. These partnerships enhance the research and development efforts within his organization.

Conclusion

Gail Isabel Reid Adam's contributions to heart failure detection exemplify the impact of innovation in healthcare. His work not only advances medical science but also holds promise for improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…